Milly Haverkort
Research Subjects
Research Interests
Milly Haverkort has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
Bas W. van der Spek
Department of Gastroenterology and Hepatology, VU University Medical Center, Amsterdam
2 shared publicationsHarry Bodde
Center for Bio-Pharmaceutical Sciences, University of Leiden, 2300 RC Leiden, The Netherlands
2 shared publicationsJohanna Kempenaar
Department of Dermatology, University Hospital Leiden, P.O. Box 9600
2 shared publicationsMaria Ponec
Department of Dermatology, University Hospital Leiden, The Netherlands
2 shared publicationsYou Lan Soei
Department of Dermatology, University Hospital Leiden, P.O. Box 9600
2 shared publications- Aldert Bart
Academisch Medisch Centrum, Amsterdam, The Netherlands
1 shared publication
Latest Publications
- 17 January 2025
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 231 (4) , 940-945
Shortened SARS-CoV-2 Viral RNA Shedding in Saliva During Early Omicron Compared to Wild-Type Pandemic Phase
This study compared the dynamics of SARS-CoV-2 viral shedding in saliva between wild-type virus–infected and Omicron-infected household cohorts. Preexisting immunity in participants likely shortens the viral RNA shedding duration and lowers viral load peaks. Frequent saliva sampling can be a convenient tool to study viral load dynamics.
- 17 January 2025
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 231 (4) , 940-945
Shortened SARS-CoV-2 Viral RNA Shedding in Saliva During Early Omicron Compared to Wild-Type Pandemic Phase
This study compared the dynamics of SARS-CoV-2 viral shedding in saliva between wild-type virus–infected and Omicron-infected household cohorts. Preexisting immunity in participants likely shortens the viral RNA shedding duration and lowers viral load peaks. Frequent saliva sampling can be a convenient tool to study viral load dynamics.
- 1 May 2016
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 83 (5) , AB511
Mo2054 Endoscopic Full-Thickness Resection With the Novel FTRD® System From OVESCO Endoscopy AG: Report on the First Dutch Experience
- 1 May 2016
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 83 (5) , AB511
Mo2054 Endoscopic Full-Thickness Resection With the Novel FTRD® System From OVESCO Endoscopy AG: Report on the First Dutch Experience
- Open Access
- 12 October 2011
- Published by Oxford University Press (OUP) in Journal of Travel Medicine
- Vol. 18 (6) , 425-426
New England Souvenirs
A 54‐year‐old woman presented with 2 weeks of fever after a trip to the Northeastern United States. Except for an erythematous skin lesion on her right shoulder, no physical abnormality was detected. We diagnosed concomitant borreliosis and babesiosis. Both infections were possibly acquired by one bite from Ixodes scapularis.
- 12 October 2011
- Published by Oxford University Press (OUP) in Journal of Travel Medicine
- Vol. 18 (6) , 425-426
Open AccessNew England Souvenirs
A 54‐year‐old woman presented with 2 weeks of fever after a trip to the Northeastern United States. Except for an erythematous skin lesion on her right shoulder, no physical abnormality was detected. We diagnosed concomitant borreliosis and babesiosis. Both infections were possibly acquired by one bite from Ixodes scapularis.
- 12 May 2011
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 43 (10) , 821-826
Tenofovir-induced Fanconi syndrome and osteomalacia in two HIV-infected patients: Role of intracellular tenofovir diphosphate levels and review of the literature
We present 2 human immunodeficiency virus-infected patients with tenofovir disoproxil fumarate-induced Fanconi syndrome, leading to osteomalacia. Intracellular tenofovir diphosphate levels were measured in 1 patient and were found to be very high, with plasma tenofovir levels just slightly elevated. Fibroblast growth factor-23, a phosphaturic hormone, was decreased in both patients and is therefore unlikely to have a pathophysiological role in this pathology. The different potential factors contributing to the development of tenofovir-related kidney proximal tubular dysfunction are discussed and the data presented may help to further elucidate its pathogenesis.
- 12 May 2011
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 43 (10) , 821-826
Tenofovir-induced Fanconi syndrome and osteomalacia in two HIV-infected patients: Role of intracellular tenofovir diphosphate levels and review of the literature
We present 2 human immunodeficiency virus-infected patients with tenofovir disoproxil fumarate-induced Fanconi syndrome, leading to osteomalacia. Intracellular tenofovir diphosphate levels were measured in 1 patient and were found to be very high, with plasma tenofovir levels just slightly elevated. Fibroblast growth factor-23, a phosphaturic hormone, was decreased in both patients and is therefore unlikely to have a pathophysiological role in this pathology. The different potential factors contributing to the development of tenofovir-related kidney proximal tubular dysfunction are discussed and the data presented may help to further elucidate its pathogenesis.
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
A Descriptive Retrospective Cohort Study on the Use of Small-Caliber Endoscopes in an Academic Hospital
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
A Descriptive Retrospective Cohort Study on the Use of Small-Caliber Endoscopes in an Academic Hospital
- Open Access
- 8 November 2010
- Published by Wiley in Journal of the International AIDS Society
- Vol. 13 (S4) , 1-P87
Intracellular tenofovir‐diphosphate accumulation in an HIV‐infected patient with Fanconi syndrome and osteomalacia
7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK
- 8 November 2010
- Published by Wiley in Journal of the International AIDS Society
- Vol. 13 (S4) , 1-P87
Open AccessIntracellular tenofovir‐diphosphate accumulation in an HIV‐infected patient with Fanconi syndrome and osteomalacia
7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK
- Open Access
- 15 March 2009
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 48 (6) , 764-765
One of the Many Faces of Immune Reconstitution Inflammatory Syndrome
A 45-year-old white man who lived in The Netherlands was admitted to the hospital with a 2-month history of watery diarrhea, peripheral edema, easy bruising, and frequent nose bleeds. He had received a diagnosis of HIV infection and chronic hepatitis B virus infection 1 year earlier, when he had presented with weight loss and oral candidiasis. The patient's initial CD4+ cell count was 36 cells/mm3, and he had initiated HAART with lamivudine, tenofovir, and lopinavir-ritonavir. The patient's virological response was good, his CD4+ cell count increased to 112 cells/mm3, and his condition improved. The patient's hepatitis B viral load decreased from 503 million copies/mL to undetectable levels (<2000 copies/mL), probably as a result of hepatitis B virus suppression by lamivudine and tenofovir. Physical examination at presentation revealed cachexia, hepatosplenomegaly, and axillary lymphadenopathy. Laboratory test results revealed pancytopenia, renal insufficiency (creatinine clearance, 25 mL/min), proteinuria (5.4 g per day), and hematuria. Microbiological and parasitological investigation of stool samples did not reveal pathogens. Colonic and gastroduodenal mucosa appeared to be normal on endoscopic evaluation, but microscopic examination demonstrated the presence of intracellular inclusions, which were also detected in bone marrow specimens (figure 1). Light and electron microscopic evaluation of a renal tissue specimen showed intracapillary proliferative glomerulonephritis, with intracellular inclusions in interstitial space, in glomeruli, and between tubular endothelial cells (figure 2).
- 15 March 2009
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 48 (6) , 764-765
Open AccessOne of the Many Faces of Immune Reconstitution Inflammatory Syndrome
A 45-year-old white man who lived in The Netherlands was admitted to the hospital with a 2-month history of watery diarrhea, peripheral edema, easy bruising, and frequent nose bleeds. He had received a diagnosis of HIV infection and chronic hepatitis B virus infection 1 year earlier, when he had presented with weight loss and oral candidiasis. The patient's initial CD4+ cell count was 36 cells/mm3, and he had initiated HAART with lamivudine, tenofovir, and lopinavir-ritonavir. The patient's virological response was good, his CD4+ cell count increased to 112 cells/mm3, and his condition improved. The patient's hepatitis B viral load decreased from 503 million copies/mL to undetectable levels (<2000 copies/mL), probably as a result of hepatitis B virus suppression by lamivudine and tenofovir. Physical examination at presentation revealed cachexia, hepatosplenomegaly, and axillary lymphadenopathy. Laboratory test results revealed pancytopenia, renal insufficiency (creatinine clearance, 25 mL/min), proteinuria (5.4 g per day), and hematuria. Microbiological and parasitological investigation of stool samples did not reveal pathogens. Colonic and gastroduodenal mucosa appeared to be normal on endoscopic evaluation, but microscopic examination demonstrated the presence of intracellular inclusions, which were also detected in bone marrow specimens (figure 1). Light and electron microscopic evaluation of a renal tissue specimen showed intracapillary proliferative glomerulonephritis, with intracellular inclusions in interstitial space, in glomeruli, and between tubular endothelial cells (figure 2).
- 1 October 2008
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 8 (10) , 586-587
Mycoplasma pneumoniae infection with incomplete Stevens-Johnson syndrome
- 1 October 2008
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 8 (10) , 586-587
Mycoplasma pneumoniae infection with incomplete Stevens-Johnson syndrome
- 15 August 2007
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 45 (5) , 600-601
Quality of Life After Starting Highly Active Antiretroviral Therapy for Chronic HIV-1 Infection at Different CD4 Cell Counts
- 15 August 2007
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 45 (5) , 600-601
Quality of Life After Starting Highly Active Antiretroviral Therapy for Chronic HIV-1 Infection at Different CD4 Cell Counts
- 1 January 2001
- Vol. 43 (2) , 54-6
Local treatment of facial lipodystrophy in patients receiving HIV protease inhibitor therapy.
Localized facial lipodystrophy is a socially disabling complication affecting many HIV-seropositive patients receiving triple combination therapy. The exact pathogenesis is not well understood and proper therapy is not available. The purpose of this pilot-study was to determine whether a hyaluronic acid get, used to treat wrinkles for cosmetic reasons, would be a safe and effective treatment for facial lipodystrophy in patients receiving triple combination therapy. Seven patients were treated with intradermal gel injections after skin tests. There were no immediate or late allergenic reactions or other side effects. Within the limitations of the product, overall satisfaction regarding the results was high.
- 1 January 2001
- Vol. 43 (2) , 54-6
Local treatment of facial lipodystrophy in patients receiving HIV protease inhibitor therapy.
Localized facial lipodystrophy is a socially disabling complication affecting many HIV-seropositive patients receiving triple combination therapy. The exact pathogenesis is not well understood and proper therapy is not available. The purpose of this pilot-study was to determine whether a hyaluronic acid get, used to treat wrinkles for cosmetic reasons, would be a safe and effective treatment for facial lipodystrophy in patients receiving triple combination therapy. Seven patients were treated with intradermal gel injections after skin tests. There were no immediate or late allergenic reactions or other side effects. Within the limitations of the product, overall satisfaction regarding the results was high.